Bhat’s group has reported the ability of AZA-ST 8a and 8c (Figure 11) to inhibit the growth of human breast cancer cell lines (MDA-MB-231, which is estrogen receptors (ER) negative and expresses mutated p53, and T47D, which is ERα positive) [46,65,66]. This evidence concerns the gene ESR1 and breast cancer.